BrightPath Biotherapeutics Co., Ltd.
4594.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | ¥1,253 | ¥901 | ¥810 | ¥1,261 |
| Short-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Receivables | ¥0 | ¥0 | ¥65 | ¥0 |
| Inventory | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Assets | ¥33 | ¥25 | ¥13 | ¥140 |
| Total Curr. Assets | ¥1,647 | ¥1,161 | ¥1,071 | ¥1,401 |
| Property Plant & Equip (Net) | ¥0 | ¥0 | ¥0 | ¥0 |
| Goodwill | ¥0 | ¥0 | ¥0 | ¥0 |
| Intangibles | ¥0 | ¥0 | ¥0 | ¥0 |
| Long-Term Investments | ¥0 | ¥0 | ¥0 | ¥0 |
| Tax Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Assets | ¥51 | ¥49 | ¥49 | ¥49 |
| Total NC Assets | ¥51 | ¥49 | ¥49 | ¥49 |
| Other Assets | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Assets | ¥1,698 | ¥1,211 | ¥1,121 | ¥1,450 |
| Liabilities | – | – | – | – |
| Payables | ¥0 | ¥0 | ¥0 | ¥0 |
| Short-Term Debt | ¥0 | ¥0 | ¥25 | ¥163 |
| Tax Payable | ¥16 | ¥0 | ¥0 | ¥0 |
| Deferred Revenue | ¥0 | ¥0 | ¥0 | ¥0 |
| Other Curr. Liab. | ¥88 | ¥86 | ¥90 | ¥79 |
| Total Curr. Liab. | ¥105 | ¥93 | ¥132 | ¥251 |
| LT Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Rev, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Deferred Tax Liab, NC | ¥0 | ¥0 | ¥0 | ¥0 |
| Other NC Liab. | ¥67 | ¥66 | ¥64 | ¥67 |
| Total NC Liab. | ¥67 | ¥66 | ¥64 | ¥67 |
| Other Liabilities | ¥0 | ¥0 | ¥0 | ¥0 |
| Cap. Leases | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liabilities | ¥171 | ¥159 | ¥196 | ¥318 |
| Equity | – | – | – | – |
| Pref Stock | ¥0 | ¥0 | ¥0 | ¥0 |
| Common Stock | ¥1,733 | ¥1,385 | ¥1,200 | ¥1,135 |
| Retained Earnings | -¥4,268 | -¥4,047 | -¥3,805 | -¥3,469 |
| AOCI | ¥20 | ¥21 | ¥22 | ¥22 |
| Other Equity | ¥0 | ¥0 | ¥0 | -¥0 |
| Total Equity | ¥1,526 | ¥1,052 | ¥925 | ¥1,132 |
| Supplemental Information | – | – | – | – |
| Minority Interest | ¥0 | ¥0 | ¥0 | ¥0 |
| Total Liab. & Tot. Equity | ¥1,698 | ¥1,211 | ¥1,121 | ¥1,450 |
| Net Debt | -¥1,253 | -¥901 | -¥785 | -¥1,098 |